Paul K. Audhya Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

Paul K. Audhya is CHIEF MEDICAL OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 122,505 shares of KALV, which is worth approximately $1.45 Million. The most recent transaction as insider was on Aug 25, 2025, when has been sold 2,336 shares (Common Stock) at a price of $13.42 per share, resulting in proceeds of $31,349. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K

8.39% 3M change

46.28% 12M change

Total Value Held $1.45 Million

Paul K. Audhya Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2025	SELL Open market or private sale	$31,349 $13.42 p/Share	2,336 Reduced 1.87%	122,505 Common Stock
Aug 22 2025	SELL Open market or private sale	$38,893 $13.22 p/Share	2,942 Reduced 2.4%	119,841 Common Stock
Aug 22 2025	BUY Exercise of conversion of derivative security	-	5,000 Added 3.85%	124,841 Common Stock
Aug 21 2025	BUY Exercise of conversion of derivative security	-	6,250 Added 4.84%	122,783 Common Stock
Aug 18 2025	SELL Open market or private sale	$38,765 $13.19 p/Share	2,939 Reduced 2.46%	116,533 Common Stock
Aug 17 2025	BUY Exercise of conversion of derivative security	-	6,446 Added 5.12%	119,472 Common Stock
May 23 2025	SELL Open market or private sale	$24,271 $11.31 p/Share	2,146 Reduced 1.86%	113,026 Common Stock
May 22 2025	SELL Open market or private sale	$31,945 $11.88 p/Share	2,689 Reduced 2.38%	110,172 Common Stock
May 22 2025	BUY Exercise of conversion of derivative security	-	5,000 Added 4.16%	115,172 Common Stock
May 21 2025	BUY Exercise of conversion of derivative security	-	6,250 Added 5.25%	112,861 Common Stock
May 19 2025	SELL Open market or private sale	$32,867 $11.84 p/Share	2,776 Reduced 2.54%	106,611 Common Stock
May 17 2025	BUY Exercise of conversion of derivative security	-	6,447 Added 5.57%	109,387 Common Stock
Feb 24 2025	SELL Open market or private sale	$23,987 $10.02 p/Share	2,394 Reduced 2.27%	102,940 Common Stock
Feb 22 2025	BUY Exercise of conversion of derivative security	-	5,000 Added 4.53%	105,334 Common Stock
Feb 18 2025	SELL Open market or private sale	$30,687 $9.82 p/Share	3,125 Reduced 3.02%	100,334 Common Stock
Feb 17 2025	BUY Exercise of conversion of derivative security	-	6,447 Added 5.87%	103,459 Common Stock
Nov 26 2024	SELL Open market or private sale	$21,585 $9.87 p/Share	2,187 Reduced 2.2%	97,012 Common Stock
Nov 22 2024	BUY Exercise of conversion of derivative security	-	5,000 Added 4.8%	99,199 Common Stock
Nov 18 2024	SELL Open market or private sale	$74,793 $9.26 p/Share	8,077 Reduced 7.9%	94,199 Common Stock
Nov 17 2024	BUY Exercise of conversion of derivative security	-	18,531 Added 15.34%	102,276 Common Stock
Aug 23 2024	SELL Open market or private sale	$26,474 $12.4 p/Share	2,135 Reduced 2.49%	83,745 Common Stock
Aug 22 2024	BUY Exercise of conversion of derivative security	-	5,000 Added 5.5%	85,880 Common Stock
Aug 19 2024	SELL Open market or private sale	$95,755 $12.01 p/Share	7,973 Reduced 8.97%	80,880 Common Stock
Aug 17 2024	BUY Exercise of conversion of derivative security	-	18,528 Added 17.25%	88,853 Common Stock
May 20 2024	SELL Open market or private sale	$154,938 $11.76 p/Share	13,175 Reduced 15.78%	70,325 Common Stock

PKA

Paul K. Audhya

CHIEF MEDICAL OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Value

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

Operation

Value

Type

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV

Account